Treatment of dementia-associated agitation with Gabapentin

David M. Roane, Todd E. Feinberg, Laurie Meckler, Christian R. Miner, Angela Scicutella, Richard N. Rosenthal

Research output: Contribution to journalArticlepeer-review

40 Scopus citations


The authors describe the use of gabapentin in the treatment of 4 outpatients with dementia-associated agitation. On the basis of clinical case reports and the Overt Agitation Severity Scale, all 4 patients had reduced agitation with gabapentin. Three of 4 patients were successfully titrated to a full dose of 2,400 mg/day. These findings suggest a possible role for gabapentin in the behavioral management of patients with dementia.

Original languageEnglish
Pages (from-to)40-43
Number of pages4
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Issue number1
StatePublished - 2000
Externally publishedYes


Dive into the research topics of 'Treatment of dementia-associated agitation with Gabapentin'. Together they form a unique fingerprint.

Cite this